These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1126 related articles for article (PubMed ID: 2979857)

  • 1. Bone marrow and peripheral blood modifications in C57BL mice administered with cyclophosphamide and levan.
    Siegal A; Kopel S; Bar-Sela S; Davidai G; Yavetz H; Leibovici J
    In Vivo; 1988; 2(5):349-59. PubMed ID: 2979857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cyclophosphamide and levan treatment on bone marrow and peripheral blood cells in B16-F10 melanoma-bearing mice.
    Leibovici J; Siegal A; Kopel S; Davidai G; Yavetz H
    Int J Immunopharmacol; 1989; 11(2):133-47. PubMed ID: 2703278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further observations on the effect of cyclophosphamide on intratumor and peripheral leukocyte levels.
    Evans R
    Am J Pathol; 1980 Jun; 99(3):667-84. PubMed ID: 7386598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined interleukin 1 beta/interleukin 2 treatment in mice: synergistic myelostimulatory activity and protection against cyclophosphamide-induced myelosuppression.
    Proietti E; Tritarelli E; Gabriele L; Testa U; Greco G; Pelosi E; Gabbianelli M; Belardelli F; Peschle C
    Cancer Res; 1993 Feb; 53(3):569-76. PubMed ID: 8425189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide.
    Schlick E; Ruffmann R; Chirigos MA; Welker RD; Herberman RB
    Cancer Res; 1985 Mar; 45(3):1108-14. PubMed ID: 3871661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite effects on tumor growth depending on dose of an immunomodulatory polysaccharide with or without cyclophosphamide.
    Leibovici J; Kopel S; Wolman M
    Anticancer Res; 1985; 5(5):553-8. PubMed ID: 4062258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic examination of bone marrow cells and peripheral lymphocytes in rats exposed to cyclophosphamide.
    Topinková E; Srám RJ
    Folia Biol (Praha); 1982; 28(5):302-10. PubMed ID: 7173448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tumor inhibitory and stimulatory doses of levan, alone and in combination with cyclophosphamide, on spleen and lymph nodes.
    Leibovici J; Kopel S; Siegal A; Gal-Mor O
    Int J Immunopharmacol; 1986; 8(4):391-403. PubMed ID: 3744640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct antitumor effect of the polysaccharide levan in mice: effects of drug concentration and time and temperature of incubation.
    Leibovici J; Stark Y
    J Natl Cancer Inst; 1984 Jun; 72(6):1417-20. PubMed ID: 6587158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cyclophosphamide on murine bone marrow and splenic megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cell levels.
    Yeager AM; Levin FC; Levin J
    J Cell Physiol; 1982 Aug; 112(2):222-8. PubMed ID: 7119022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of 2-chlorodeoxyadenosine alone and in combination with cyclophosphamide or methotrexate on normal hematopoiesis in mice.
    Góra-Tybor J; Robak T
    Acta Haematol Pol; 1993; 24(3):281-7. PubMed ID: 7902635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of cyclophosphamide on lymph node and peripheral blood lymphocytes in mice.
    Mackiewicz U; Brelińska-Peczalska R; Konys J
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):375-80. PubMed ID: 749786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophosphamide-induced changes in the cellular composition of a methylcholanthrene-induced tumor and their relation to bone marrow and blood leukocyte levels.
    Evans R; Madison LD; Eidlen DM
    Cancer Res; 1980 Feb; 40(2):395-402. PubMed ID: 7356522
    [No Abstract]   [Full Text] [Related]  

  • 14. Accumulation and persistence of cyclophosphamide-induced sister chromatid exchange in murine peripheral blood lymphocytes.
    Takeshita T; Conner MK
    Cancer Res; 1984 Sep; 44(9):3820-4. PubMed ID: 6744298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel anti-inflammatory function of human galectin-1: inhibition of hematopoietic progenitor cell mobilization.
    Kiss J; Kunstár A; Fajka-Boja R; Dudics V; Tóvári J; Légrádi A; Monostori E; Uher F
    Exp Hematol; 2007 Feb; 35(2):305-13. PubMed ID: 17258079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice.
    Zhu XL; Chen AF; Lin ZB
    J Ethnopharmacol; 2007 May; 111(2):219-26. PubMed ID: 17182202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of donor-reactive cells as a new concept for improvement of mismatched bone marrow engraftment using reduced-intensity conditioning.
    Prigozhina TB; Elkin G; Khitrin S; Slavin S
    Exp Hematol; 2004 Nov; 32(11):1110-7. PubMed ID: 15539090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of total saponins from stem and leaf of Panax ginseng against cyclophosphamide-induced genotoxicity and apoptosis in mouse bone marrow cells and peripheral lymphocyte cells.
    Zhang QH; Wu CF; Duan L; Yang JY
    Food Chem Toxicol; 2008 Jan; 46(1):293-302. PubMed ID: 17904265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of H2 antagonists cimetidine and famotidine on the hemotoxicity of cyclophosphamide.
    Lerza RA; Bogliolo GV; Mencoboni MP; Saviane AG; Pannacciulli IM
    Anticancer Res; 1988; 8(6):1241-5. PubMed ID: 2905881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered mouse bone marrow glutathione and glutathione transferase levels in response to cytotoxins.
    Adams KJ; Carmichael J; Wolf CR
    Cancer Res; 1985 Apr; 45(4):1669-73. PubMed ID: 3978635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.